SlideShare is now on Android. 15 million presentations at your fingertips.  Get the app

×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Gsk subsidiary sb pharmaco signs settlement deal with 37 states

by on Feb 22, 2012

  • 533 views

http://www.paxilbirthdefectlaw.com/ Losing a costly legal battle with the US federal government, SB Pharmaco Inc. and its parent holding firm GlaxoSmithKline (GSK) paid $750 million in penalties for ...

http://www.paxilbirthdefectlaw.com/ Losing a costly legal battle with the US federal government, SB Pharmaco Inc. and its parent holding firm GlaxoSmithKline (GSK) paid $750 million in penalties for failing to comply with drug production standards, court records show. The civil suit against the company was supported by a whistleblower as regards the production and distribution of adulterated batches of some drugs. These drugs include Kytril, Avandamet, Bactroban and Paxil CR.

Statistics

Views

Total Views
533
Views on SlideShare
533
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via SlideShare as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Gsk subsidiary sb pharmaco signs settlement deal with 37 states Gsk subsidiary sb pharmaco signs settlement deal with 37 states Presentation Transcript